Intensity Therapeutics Inc
intensitytherapeutics.comWhat Do They Do?
Develops injectable cancer drug candidates designed to treat solid tumors and activate immune responses in cancer patients.
10-K for FY2025, filed Mar 27, 2026Intensity Therapeutics, Inc. is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the…View ↗
Intratumoral (“IT”) treatment, or treatment designed to contain a drug inside a tumor without spreading to the rest of the body, has been…View ↗
Our platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Amphiphilic…View ↗
Who Do They Compete With?
Competes with Amgen, AstraZeneca, Bristol-Myers Squibb, Gilead Sciences, Merck &, Merck KGA, Novartis, Pfizer, Regeneron, Roche, Eli Lilly, GlaxoSmithKline, Replimune Group, ImmVira, IconOVir Bio, and FerGene
10-K for FY2025, filed Mar 27, 2026The development and commercialization of new product candidates is highly competitive. We face competition from major pharmaceutical…View ↗
Loading...
